Leadership: Cultivating a Culture of High CuriosityThe bar is set high for Medical Affairs (MA) talent: traditional capabilities are no longer sufficient to address Share XLeadership: Cultivating a Culture of High Curiosityhttps://pharmaphorum.com/partner-content-market-access/leadership-cultivating-a-culture-of-high-curiosity/
MAPS 2018 EMEA Annual MeetingThe Medical Affairs Professionals Society (MAPS) presents its inaugral European conference this year, created by medical affairs professionals, Share XMAPS 2018 EMEA Annual Meetinghttps://pharmaphorum.com/partner-content/events-partner-content/maps-2018-emea-annual-meeting/
Cementing the Value of Medical AffairsA number of trends including tougher regulatory controls, increased transparency expectations, an increasingly vocal patient and greater requirements Share XCementing the Value of Medical Affairshttps://pharmaphorum.com/views-analysis-sales-marketing/cementing-value-medical-affairs/
FDA names MDMA a ‘breakthrough’ for post-traumatic stressUS non-profit organisation to begin late-stage trials this year Share XFDA names MDMA a ‘breakthrough’ for post-traumatic stresshttps://pharmaphorum.com/news/fda-backs-late-stage-trial-mdma-post-traumatic-stress/
Medical Affairs – the heart of a data-driven, patient-centric pharmaKirk Shepard, Eisai’s SVP of Global Medical Affairs Oncology, talks about how his profession has developed hugely in Share XMedical Affairs – the heart of a data-driven, patient-centric pharmahttps://pharmaphorum.com/views-and-analysis/medical-affairs-heart-data-driven-patient-centric-pharma/